1       Introduction
1.1     Objective
1.2     Market Introduction
1.3     Market Scope
1.4     Methodology
1.5     Scenario based Forecast
1.6     Who will benefit from this report?
1.6.1   Business Leaders & Business Developers
1.6.2   Lutein Professionals
1.6.3   Policy Makers, Budget Planners and Decision Makers
1.6.4   Civil Government Leaders & Planners
1.6.5   Financial analysts, Investors, Consultants
1.7     Language

2       Executive Summary
2.1     Lutein Market Trends and Insights
2.2     Top Five Major Findings
2.3     Major Conclusion
2.4     Important Tables and Graphs

3       Current Market Overview of the Lutein Market
3.1     Market Overview
3.2     Sources of Lutein
3.3     Applications of Lutein
3.3.1   Antioxidants
3.3.2   Lutein in Eye Health:
3.3.3   Lutein Necessary for Healthy Skin

4       Current Market Trends of the Global Lutein Market
4.1     Bioavailability
4.2     Extraction of Lutein:
4.2.1   Extraction from marigold flowers
4.2.2   Extraction from microalga biomass
4.2.3   Extraction from microalga Chlorella Vulgaris
4.2.4   Extraction from Corn
4.3     In vitro study to evaluate lutein’s Bioaccessibility
4.4     In vivo study to evaluate lutein’s bioavailability
4.5     Lutein Degradation
4.6     Prevention of lutein degradation in food matrix:
4.7     Side Effects of Lutein:

5       Market Dynamics
5.1     Drivers
5.1.1   High Bioavailability
5.1.2   Health Problems
5.1.3   Demand for natural colorants.
5.1.4   Aquaculture Industry
5.2     Restraints
5.2.1   Side effects of Lutein
5.2.2   Government Regulations
5.2.3   Availability in Nature
5.3     Challenges
5.3.1   High Cost of Natural Colors:
5.3.2   Lutein- An Unstable Compound
5.3.3   Difficulty in separating Lutein and Zeaxanthin
5.4     PEST
5.4.1   Political
5.4.2   Economic
5.4.3   Social
5.4.4   Technology
5.5     Porter’s Five Forces
5.5.1   Buyer’s Bargaining Power
5.5.2   Suppliers Bargaining Power
5.5.3   Threat of New Entrants
5.5.4   Threat of Substitutes
5.5.5   Rivalry among Competitors

6       Country Analysis
6.1     United States of America (USA)
6.1.1   Introduction
6.1.2   Chronic Disease of USA (2020)
6.1.3   Healthcare Initiatives
6.2     Canada
6.2.1   Introduction
6.2.2   Chronic diseases in Canada
6.2.3   Healthcare Initiatives
6.3     France
6.3.1   Introduction
6.3.2   Chronic Diseases in France
6.3.3   Healthcare Initiatives
6.4     Germany
6.4.1   Introduction
6.4.2   Chronic Diseases in Germany
6.4.3   Healthcare Initiatives
6.5     Spain
6.5.1   Introduction
6.5.2   Chronic diseases in Spain.
6.5.3   Healthcare Initiatives
6.6     Portugal
6.6.1   Introduction
6.6.2   Chronic Diseases in Portugal
6.6.3   Healthcare Initiatives
6.7     Denmark
6.7.1   Introduction
6.7.2   Chronic Diseases in Denmark
6.7.3   Healthcare Initiatives
6.8     Netherlands
6.8.1   Introduction
6.8.2   Chronic Diseases in Netherlands
6.8.3   Healthcare Initiatives
6.9     Sweden
6.9.1   Introduction
6.9.2   Chronic Diseases in Sweden
6.9.3   Healthcare Initiatives
6.10    Finland
6.10.1  Introduction
6.10.2  Chronic diseases in Finland
6.10.3  Healthcare Initiatives
6.11    United Kingdom (UK)
6.11.1  Introduction
6.11.2  Chronic Diseases in UK
6.11.3  Healthcare Initiatives
6.12    Switzerland
6.12.1  Introduction
6.12.2  Chronic diseases in Switzerland
6.12.3  Healthcare Initiatives
6.13    Israel
6.13.1  Introduction
6.13.2  Chronic diseases in Israel
6.13.3  Healthcare Initiatives
6.14    Turkey
6.14.1  Introduction
6.14.2  Chronic diseases in Turkey
6.14.3  Healthcare Initiatives
6.15    Italy
6.15.1  Introduction
6.15.2  Chronic Diseases in Italy
6.15.3  Healthcare Indicator
6.16    Japan
6.16.1  Introduction
6.16.2  Chronic Diseases in Japan
6.16.3  Healthcare Initiatives
6.17    India
6.17.1  Introduction
6.17.2  Chronic disease in India
6.17.3  Health Initiatives
6.18    Australia
6.18.1  Introduction
6.18.2  Chronic Diseases in Australia
6.18.3  Healthcare Initiatives
6.19    China
6.19.1  Introduction
6.19.2  Chronic diseases in China
6.19.3  Healthcare Initiatives
6.20    Russia
6.20.1  Introduction
6.20.2  Chronic diseases in Russia
6.20.3  Healthcare Initiatives

7       Global Lutein Market Forecast by Region to 2028
7.1     Total Global Market by Region to 2028
7.2     Total Global Market by Region (By Applications) to 2028
7.2.1   North America
7.2.2   Europe
7.2.3   APAC
7.2.4   Middle East
7.2.5   LATAM
7.2.6   Rest of the World
7.3     Total Global Market by Region (By Form) to 2028
7.3.1   North America
7.3.2   Europe
7.3.3   7.3.3 APAC
7.3.4   Middle East
7.3.5   LATAM
7.3.6   Rest of the World

8       Lutein Market Forecast by Form to 2028
8.1     Total Global Market by Form to 2028
8.2     Total Global Market by Form (By Applications) to 2028
8.2.1   Powder & Crystalline
8.2.2   Beadlets
8.2.3   Oil Suspension
8.2.4   Emulsion
8.3     Total Global Market by Form (By Source) to 2028
8.3.1   Powder & Crystalline
8.3.2   Beadlets
8.3.3   Oil Suspension
8.3.4   Emulsion

9       Lutein Market Forecast by Source to 2028
9.1     Total Global Market by Source to 2028
9.2     Total Global Market by Source (By Applications) to 2028
9.2.1   Natural
9.2.2   Synthetic
9.3     Total Global Market by Source (By Process) to 2028
9.3.1   Natural
9.3.2   Synthetic

10      Scenario Analysis
10.1    Introduction
10.2    Scenario Analysis 1
10.3    Scenario Analysis 2

11      Opportunity Analysis
11.1    By Region
11.2    By Form
11.3    By Source

12      Company Profiling
12.1    BASF
12.1.1  Company Profile
12.1.2  Segment Revenue
12.1.3  Financial info (revenues, profit last 5 years)
12.1.4  Recent Contract(s) Won
12.1.5  Recent Projects Completed
12.1.6  Strategic Alliances
12.1.7  SWOT Analysis
12.2    Chr. Hansen
12.2.1  Company Profile
12.2.2  Products & Services
12.2.3  Segment Revenue
12.2.4  Financial info (revenues, profit last 5 years)
12.2.5  Recent Contract(s) Won
12.2.6  Recent Projects Completed
12.2.7  Strategic Alliances
12.2.8  SWOT Analysis
12.3    E.I.D Parry
12.3.1  Company Profile
12.3.2  Products & Services
12.3.3  Financial info (revenues, profit last 5 years)
12.3.4  Recent Contract(s) Won
12.3.5  Recent Projects Completed
12.3.6  Strategic Alliances
12.3.7  SWOT Analysis
12.4    Zhejiang Medicine
12.4.1  Company Profile
12.4.2  Financial info (revenues, profit last 5 years)
12.4.3  Strategic Alliances
12.5    Kemin
12.5.1  Company Profile
12.5.2  Products & Services
12.5.3  Recent Projects Completed
12.5.4  Strategic Alliances
12.6    Omniactive Health Technologies
12.6.1  Company Profile
12.6.2  Products & Services
12.6.3  Recent Contract(s) Won
12.6.4  Recent Projects Completed
12.6.5  Strategic Alliances
12.7    Synthite Industries
12.7.1  Company Profile
12.7.2  Products & Services
12.7.3  Recent Contract(s) Won
12.7.4  Strategic Alliances
12.7.5  SWOT Analysis
12.8    Lycored
12.8.1  Company Profile
12.8.2  Products & Services
12.8.3  Recent Contract(s) Won
12.8.4  Recent Projects Completed
12.8.5  Strategic Alliances
12.9    Allied Biotech Corporation
12.9.1  Company Profile
12.9.2  Products & Services
12.9.3  Strategic Alliances
12.10   Piveg
12.10.1 Company Profile
12.10.2 Products & Services
12.10.3 Strategic Alliances

13      Strategic Conclusions

14      Appendices
14.1    Companies Mentioned
14.2    Abbreviations

15      About Market Info Group
15.1    General
15.2    Contact us